I-Orlistat CAS:96829-58-2
Ukufaka i-Orlistat kwisicwangciso sakho sokulawula ubunzima kunokuchaphazela kakhulu inkqubo yokufunxwa kwamafutha kunye nokusetyenziswa kwawo. Njengemveliso yamayeza, i-Orlistat kufuneka isetyenziswe njengoko kuyalelwe yingcali yezempilo. Umthamo oqhelekileyo ubandakanya ukuthatha i-capsule enye ye-120-milligram kunye nesidlo ngasinye esiphambili esinamafutha, ukuya kuthi ga kathathu ngemini. Kubalulekile ukunamathela kukutya okune-calories ephantsi okunamafutha aphantsi ngelixa usebenzisa i-Orlistat ukuze usebenze kakuhle. I-Orlistat isebenza ngokuthintela isenzo se-lipase, i-enzyme enoxanduva lokuqhekeza amafutha okutya kwinkqubo yokugaya ukutya. Ngokunciphisa ukufunxwa kwamafutha, inceda ukunciphisa ukutya kweekhalori ezivela kumafutha okutya, okunokukhokelela ekunciphiseni ubunzima ngokuhamba kwexesha. Kubalulekile ukuqaphela ukuba ukusebenzisa i-Orlistat kufuna ukubekwa esweni ngokusondeleyo kwamanqanaba eevithamini ezinyibilikayo kumafutha, kubandakanya iivithamini A, D, E, kunye ne-K. Ukongeza i-multivitamin equlethe ezi zondlo kuhlala kucetyiswa, kuthathwe ubuncinci iiyure ezi-2 ngaphambi okanye emva kokunikwa i-Orlistat. Ngokudibene nokusetyenziswa kwe-Orlistat, abantu bayakhuthazwa ukuba benze umthambo rhoqo kwaye banamathele kukutya okune-calories ephantsi. Ukungaguquguquki kunye nokuzinikela ekutshintsheni indlela yokuphila kubalulekile ekufezekiseni iinjongo zokulawula ubunzima bexesha elide ngenkxaso ye-Orlistat. Yamkela amandla e-Orlistat njengenxalenye yendlela ebanzi yokulawula ubunzima obusempilweni, usebenzisana neengcali zezempilo ukuze uphucule impumelelo yakho.
| Ukwakhiwa | C29H53NO5 |
| Uvavanyo | 99% |
| Inkangeleko | Amandla amhlophe |
| Inombolo ye-CAS | 96829-58-2 |
| Ukupakisha | Encinci kwaye ininzi |
| Beka ubomi kwishelufa | iminyaka eyi-2 |
| Indawo yokugcina izinto | Gcina kwindawo epholileyo neyomileyo |
| Isiqinisekiso | I-ISO. |



![3-Amino-3-azabicyclo[3.3.0]octane CAS:58108-05-7](https://cdn.globalso.com/xindaobiotech/CMGYQWFMYMAW61CV3X60.png)




